119915-66-1

Basic information

• Product Name: ethyl 3-chloro-2,4,5-trifluoro-6-methyl-β-oxobenzenepropanoate
• Synonyms: ethyl 3-chloro-2,4,5-trifluoro-6-methyl-β-oxobenzenepropanoate
• CAS NO: 119915-66-1
• Molecular Weight: 294.658
• Mol File: 119915-66-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: ethyl 3-chloro-2,4,5-trifluoro-6-methyl-β-oxobenzenepropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-chloro-2,4,5-trifluoro-6-methyl-β-oxobenzenepropanoate(119915-66-1)
• EPA Substance Registry System: ethyl 3-chloro-2,4,5-trifluoro-6-methyl-β-oxobenzenepropanoate(119915-66-1)

Safety Data

• Hazardous Substances Data: 119915-66-1(Hazardous Substances Data)

Upstream product

• 1071-46-1 hydrogen ethyl malonate 
• 119915-64-9 3-chloro-2,4,5-trifluoro-6-methylbenzoyl chloride 
• 79-37-8 oxalyl dichloride 
• 125290-78-0 3-chloro-2,4,5-trifluoro-6-methylbenzoic acid 
• 105-53-3 diethyl malonate 
• 125290-77-9 2-(3-chloro-2,4,5-trifluoro-6-methylphenyl)-4,4-dimethyl-2-oxazoline 
• 125290-76-8 2-(3-chloro-2,4,5-trifluorophenyl)-4,4-dimethyl-2-oxazoline 
• 125290-72-4 2-(2,4,5-trifluorophenyl)-4,4-dimethyl-2-oxazoline 
• 88419-56-1 2,4,5-trifluorobenzoyl chloride 
• 446-17-3 2,4,5-trifluorobenzoic acid 

Downstream Products

• 119915-67-2 ethyl 3-chloro-α-(ethoxymethylene)-2,4,5-trifluoro-6-methyl-β-oxobenzenepropanoate 

Relevant articles and documents

Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient

PCT No. PCT/JP97/04326 Sec. 371 Date May 28, 1999 Sec. 102(e) Date May 28, 1999 PCT Filed Nov. 27, 1997 PCT Pub. No. WO98/23592 PCT Pub. Date Jun. 4, 1998The invention relates to pyridonecarboxylic acid derivatives represented by the general formula (1): wherein R1 is -OH, a carboxy-protecting group or (alkyl)amino group, R2 is H, or -NO2, (protected) amino, (protected) hydroxyl, lower alkyl or lower alkoxyl group, R3 is a halogen atom, H, or -NO2, lower alkyl, lower alkoxyl or amino group, R4 is an azido, (substituted) hydrazino, (substituted) amino, lower alkoxyl or hydroxyl group, R5, R6 and R7 are independently H, -NO2, halogen atom or lower alkyl group, R8 is a -NO2, (substituted) amino, -OH or lower alkoxyl group, A is N or C-R12, in which R12 is H, halogen atom, or (substituted) lower alkyl, lower alkenyl, lower alkynyl, lower alkoxyl, lower alkylthio or nitro group, and B is N or C-R13, in which R13 is H or halogen atom, or salts thereof, and medicine comprising such a compound as an active ingredient. The derivatives or the salts thereof exhibit excellent antibacterial action and peroral absorbability, scarcely cause side effects, and are easy of synthesis.